Published in Eur J Nucl Med Mol Imaging on July 01, 2004
Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab (2001) 4.73
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab (1995) 1.84
Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy. J Nucl Med (2001) 1.55
Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med (1996) 1.49
Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med (1993) 1.26
Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med (1987) 1.06
Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab (1994) 1.05
Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. J Clin Endocrinol Metab (2001) 0.98
131I therapy for elevated thyroglobulin levels. Thyroid (1997) 0.90
Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer. J Clin Endocrinol Metab (2002) 0.90
Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med (1988) 0.90
Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of serum thyroglobulin monitoring in tumor surveillance. Semin Nucl Med (2000) 0.88
Anaplastic changes associated with p53 gene mutation in differentiated thyroid carcinoma after insufficient radioactive iodine (131I) therapy. Thyroid (2000) 0.86
Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Eur J Endocrinol (1998) 0.84
Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark? J Clin Endocrinol Metab (1995) 0.84
Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin. Eur J Nucl Med (2001) 0.82
The significance of 1-131 scan dose in patients with thyroid cancer: determination of ablation: concise communication. J Nucl Med (1981) 0.78
Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma? Clin Endocrinol (Oxf) (2002) 0.76
Treatment of iodine negative, thyroglobulin positive, thyroid cancer patients: do we miss the target when we shoot in the dark? Nucl Med Commun (2003) 0.75
FDG PET/CT findings in primary hyperparathyroidism mimicking multiple bone metastases. Eur J Nucl Med Mol Imaging (2007) 1.46
Lymph Node/Tumor SUVmax Ratio Can Predict Metastasis to Mediastinal Lymph Nodes in Lung Cancer Patients. J Thorac Oncol (2015) 1.10
Comparison of ⁶⁸Ga-DOTATATE and ⁶⁸Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2012) 1.03
Avoidance of misinterpretation of an FDG positive sacral insufficiency fracture using PET/CT scans in a patient with endometrial cancer: a case report. Clin Nucl Med (2007) 0.90
The correlation of SUVmax with pathological characteristics of primary tumor and the value of Tumor/ Lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients. J Cardiothorac Surg (2013) 0.89
FDG PET/CT findings in recurrent malignant schwannoma. Clin Nucl Med (2008) 0.85
Temporal relationship between gastroesophageal reflux and rate of gastric emptying in children. Nucl Med Commun (2010) 0.84
Is early bladder activity in radionuclide cisternography an indirect sign of spontaneous intracranial hypotension or sequence of lumbar puncture? Clin Nucl Med (2007) 0.84
A patient with peripheral arterial stenosis diagnosed with lower extremity perfusion scintigraphy. Clin Nucl Med (2007) 0.82
Ultra-high dose of intra-amniotic or direct fetal intramuscular betamethasone for lung maturation in the preterm goat model. Eur J Obstet Gynecol Reprod Biol (2012) 0.82
Radiation protection for accompanying person and radiation workers in PET/CT. Radiat Prot Dosimetry (2010) 0.80
Coronary artery calcification and coronary ischaemia in renal transplant recipients. Nephrol Dial Transplant (2010) 0.80
Intraoperative localization of recurrent medullary carcinoma of the thyroid using Tc-99m HYNIC-TATE and a surgical gamma probe. Clin Nucl Med (2011) 0.79
Ameliorative effect of adalimumab on experimentally induced acute pancreatitis in rats. Pancreas (2010) 0.79
FDG PET/CT Findings of Recurrent Respiratory Papillomatosis With Malignant Degeneration in the Lung. Clin Nucl Med (2015) 0.78
A dynamic renal phantom for nuclear medicine studies. Med Phys (2005) 0.78
Prognostic factors in malignant pleural mesothelioma: a retrospective study of 60 Turkish patients. J Cancer Res Ther (2015) 0.78
A doughnut sign of a hydatid cyst of the liver on F-18 FDG PET/CT. Clin Nucl Med (2008) 0.77
Effects of etanercept on sodium taurocholate-induced acute pancreatitis in rats. Transl Res (2009) 0.77
Early degenerative effects of diabetes mellitus on pancreas, liver, and kidney in rats: an immunohistochemical study. Exp Diabetes Res (2012) 0.77
The Diagnostic Role of FDG PET/CT in Patients with Fever of Unknown Origin. Mol Imaging Radionucl Ther (2011) 0.76
Effect of vitamin C in reducing the toxicity of endosulfan in liver in rabbits. Exp Toxicol Pathol (2009) 0.76
Effects of Certolizumab on Cerulein-Induced Acute Pancreatitis in Rats. Pancreas (2016) 0.76
Fatal systemic cladosporiosis in a merino sheep flock. Mycopathologia (2010) 0.76
Is furosemide administration effective in improving the accuracy of determination of differential renal function by means of technetium-99m DMSA in patients with hydronephrosis. Eur J Nucl Med Mol Imaging (2002) 0.75
Glutathione S-transferase and O6-methylguanine DNA methyl transferase activities in patients with thyroid papillary carcinoma. Cancer Invest (2002) 0.75
18F-FDG-PET/CT findings in a patient with tuberculosis Hodgkin's disease and lupus vulgaris. Hell J Nucl Med (2009) 0.75
Fluoro-18 fluorodeoxyglucose positron emission tomography/computerized tomography scans in a patient with penile cancer for appropriate therapeutic strategy. Hell J Nucl Med (2007) 0.75
Intravascular radiation therapy with a Re-188 liquid-filled balloon in patients with in-stent restenosis. Nucl Med Commun (2010) 0.75
The relationship between pulmonary function tests, thorax HRCT, and quantitative ventilation-perfusion scintigraphy in chronic obstructive pulmonary disease. Tuberk Toraks (2005) 0.75
Cardiac hydatid cyst mimicking malignancy. Clin Nucl Med (2011) 0.75
Significance of increased scrotal Tc-99m MDP uptake in patients with prostate cancer. Nucl Med Commun (2011) 0.75
Ectopic parathyroid adenoma localized with MIBI scintigraphy and excised with guide of macroaggregated human serum albumin injection. Clin Nucl Med (2010) 0.75
Female breast surface radiation exposure during FDG PET/CT examinations. Nucl Med Commun (2007) 0.75
Coagulation profile, haematological and biochemical changes in kids naturally infected with peste des petits ruminants. Trop Anim Health Prod (2011) 0.75
Utility of left lateral supine position for myocardial perfusion single-photon emission computed tomography compared with other methods of correcting inferior wall attenuation. Nucl Med Commun (2015) 0.75
The value of different washout parameters in the evaluation of renal transplants by technetium-99m-ethylene- l-l-dicysteine. Hell J Nucl Med (2010) 0.75
Acute endosulfan poisoning in cattle. Vet Hum Toxicol (2003) 0.75